CEACAM1 participation in breast cancer progression
Molecular Oncology · 2026-11 · 20 (11) · 2805-2819
DOI: 10.1002/1878-0261.70306 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, online erschienen am 10.07.2026. Verfasst von Mykola Lyndin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, University Hospital Essen, Essen, Germany. Hauptthemen laut MEDLINE: Breast Neoplasms, CEACAM1 Protein, Disease Progression, Cell Adhesion Molecules. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Carcinoembryonic antigen‐related cell adhesion molecule 1 (CEACAM1) is widely expressed in human cells and undergoes marked alterations during tumorigenesis. However, its functional significance in invasive breast cancer (BC) remains insufficiently understood. In this study, CEACAM1 expression patterns in invasive BC tissues were analyzed and correlated with the proliferative index (PI) of the tumor cells. To assess isoform‐specific functional effects and identify CEACAM1‐responsive genes involved in key proliferation‐associated pathways, MCF‐7 cells were transfected with either CEACAM1 short cytoplasmic domain isoform (CEACAM1‐4S) or CEACAM1 long cytoplasmic domain isoform (CEACAM1‐4L). BC tissues exhibited substantial heterogeneity in CEACAM1 expression, which correlated with the PI of the tumor cells. Functional in vitro studies demonstrated that the CEACAM1‐4L isoform exclusively suppresses cell proliferation. Transcriptome and protein‐level analyses revealed that CEACAM1‐4L regulates the expression of key mediators involved in cell cycle control, apoptosis, extracellular matrix organization, and growth factor‐dependent signaling pathways. These findings highlight the biological significance of CEACAM1‐4L isoform in BC, its potential diagnostic relevance for patient stratification, as well as its possible consideration in future therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy, University Hospital Essen, Essen, Germany.
- Department of Pathology, Academic and Research Medical Institute, Sumy State University, Sumy, Ukraine.
ORCID-Profile: Gunther Wennemuth
Zitieren
APA
Lyndin, M., Kube-Golovin, I., Romaniuk, A., & Wennemuth, G. (2026). CEACAM1 participation in breast cancer progression. Molecular Oncology, 20(11), 2805-2819. https://doi.org/10.1002/1878-0261.70306
Vancouver
Lyndin M, Kube-Golovin I, Romaniuk A, Wennemuth G. CEACAM1 participation in breast cancer progression. Molecular Oncology. 2026;20(11):2805-2819. doi:10.1002/1878-0261.70306
BibTeX
@article{Lyndin2026,
author = {Lyndin, Mykola and Kube-Golovin, Irina and Romaniuk, Anatolii and Wennemuth, Gunther},
title = {CEACAM1 participation in breast cancer progression},
journal = {Molecular Oncology},
year = {2026},
volume = {20},
number = {11},
pages = {2805--2819},
doi = {10.1002/1878-0261.70306}
}
EUVIMED